These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1905005)

  • 21. Effects of chronic phorbol ester treatment on protein kinase C activity, content, and gene expression in the human monoblastoid U937 cell.
    Ways DK; Qin W; Garris TO; Chen J; Hao E; Cooper DR; Usala SJ; Parker PJ; Cook PP
    Cell Growth Differ; 1994 Feb; 5(2):161-9. PubMed ID: 8180129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product.
    Asano Y; Brach MA; Ahlers A; de Vos S; Butterfield JH; Ashman LK; Valent P; Gruss HJ; Herrmann F
    J Immunol; 1993 Sep; 151(5):2345-54. PubMed ID: 7689605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection and preliminary characterization of variant lines of a murine macrophage tumor resistant to the antiproliferative effects of phorbol esters.
    Goode NT; Moore JP; Hart IR
    Cancer Res; 1990 Mar; 50(5):1510-5. PubMed ID: 2105841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and expression of human c-Ha-ras and c-sis sequences in NIH3T3 transformants.
    Weismanová E; Sabová L
    Neoplasma; 1990; 37(6):675-85. PubMed ID: 2274086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase.
    Cacace AM; Ueffing M; Philipp A; Han EK; Kolch W; Weinstein IB
    Oncogene; 1996 Dec; 13(12):2517-26. PubMed ID: 9000126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A; Thraves PJ; Dritschilo A; Notario V
    Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. v-erbA cooperates with bFGF in neuroretina cell transformation.
    Garrido C; Li RP; Samarut J; Gospodarowicz D; Saule S
    Virology; 1993 Feb; 192(2):578-86. PubMed ID: 7678474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
    Arai H; Escobedo JA
    Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial down-regulation of protein kinase C in C3H 10T 1/2 mouse fibroblasts transfected with the human Ha-ras oncogene.
    Weyman CM; Taparowsky EJ; Wolfson M; Ashendel CL
    Cancer Res; 1988 Nov; 48(22):6535-41. PubMed ID: 3052806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of a new class of 'flat' revertants from ras-transformed NIH3T3 cells using cis-4-hydroxy-L-proline.
    Yanagihara K; Ciardiello F; Talbot N; McGeady ML; Cooper H; Benade L; Salomon DS; Bassin RH
    Oncogene; 1990 Aug; 5(8):1179-86. PubMed ID: 2202950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
    Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of afterload and angiotensin II on proto-oncogene mRNA levels in the isolated working rat heart.
    Roffe C; MacDiarmaid-Gordon A; Ohanian V; Hollis S; Heagerty AM
    Cardiovasc Res; 1996 Jun; 31(6):907-16. PubMed ID: 8759246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of proto-oncogene expression by phorbol esters in human dermal microvascular endothelial cells.
    Mansbridge JN; Grymes RA; Karasek MA
    Cell Mol Biol (Noisy-le-grand); 1992 Nov; 38(7):791-8. PubMed ID: 1472905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human smooth muscle myosin light chain-2 gene expression is repressed in ras transformed fibroblast cells.
    Kumar CC; Chang C
    Cell Growth Differ; 1992 Jan; 3(1):1-10. PubMed ID: 1599878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipain-induced suppression of oncogene expression in H-ras-transformed NIH3T3 cells.
    Cox LR; Motz J; Troll W; Garte SJ
    Cancer Res; 1991 Sep; 51(18):4810-4. PubMed ID: 1893373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Fos- and Ras-induced transformation by mutant Fos proteins with structural alterations in functionally different domains.
    Wick M; Lucibello FC; Müller R
    Oncogene; 1992 May; 7(5):859-67. PubMed ID: 1570155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes.
    Stacey DW; Roudebush M; Day R; Mosser SD; Gibbs JB; Feig LA
    Oncogene; 1991 Dec; 6(12):2297-304. PubMed ID: 1766676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-fos and c-myc oncoprotein expression in human hepatocellular carcinomas.
    Arbuthnot P; Kew M; Fitschen W
    Anticancer Res; 1991; 11(2):921-4. PubMed ID: 1648336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced induction of c-fos but not of c-myc expressions in a nontumorigenic revertant R1 of Ej-ras-transformed NIH/3T3 cells treated with 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Suzuki H; Fujita H; Ogiso Y; Oda A; Kuzumaki N; Uchino J
    Exp Cell Res; 1989 Oct; 184(2):524-8. PubMed ID: 2509225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential expression of the dbl protooncogene in some tumors of neuroectodermal origin.
    de Franciscis V; Rosati R; Colucci-D'Amato GL; Eva A; Vecchio G
    Cancer Res; 1991 Aug; 51(16):4234-7. PubMed ID: 1868443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.